Warning: Attempt to read property "labels" on null in /home/sumairafr/public_html/wp-includes/general-template.php on line 1539

Warning: Attempt to read property "name" on null in /home/sumairafr/public_html/wp-includes/general-template.php on line 1539
Events from January 19, 2025 – January 19, 2025 – The Sumaira Foundation
Warning: Attempt to read property "labels" on null in /home/sumairafr/public_html/wp-includes/general-template.php on line 3261

Warning: Attempt to read property "name" on null in /home/sumairafr/public_html/wp-includes/general-template.php on line 3261

Warning: Attempt to read property "name" on null in /home/sumairafr/public_html/wp-includes/general-template.php on line 3264
Faire un donContactez-nous
Visit us on Facebook Visit us on Twitter Visit us on YouTube Visit us on Instagram Visit us on Linkedin

Latest Past Events

NMOSD, MOGAD en MS: Overeenkomsten en Verschillen

Virtual: Global

Neem vrijdag 17 maart van 20.00-21.00 uur deel aan het allereerste Nederlandstalige webinar “In gesprek met deskundigen” (“From the Experts”). Dit webinar wordt georganiseerd door de Sumaira Foundation. Dr Barbara Willekens zal spreken over overeenkomsten en verschillen tussen NMOSD, MOGAD en MS. Dr. Willekens is als neurologe verbonden aan het UZA, het Universitair Ziekenhuis Antwerpen. […]

NMOSD, MOGAD und MS: Gemeinsamkeiten und Unterschiede

Virtual: Germany

Herzliche Einladung zum ersten Live-Webinar "NMOSD, MOGAD und MS: Gemeinsamkeiten und Unterschiede" der Sumaira-Foundation für die deutschsprachige NMOSD & MOGAD Community am Montag, den 13. Februar, mit Dr. Joachim Havla, Neurologe und NMOSD/MOGAD-Spezialist an der Ludwig-Maximilians-Universität München. Dr. Havla wird die Gemeinsamkeiten und Unterschiede zwischen NMOSD, MOGAD und die Abgrenzung gegenüber der Multiplen Sklerose erläutern. […]

Young People’s Webinar | Connecting MS, NMOSD & MOGAD: Sharing Knowledge and Experiences to Strengthen Our Communities

Virtual: Danmark

There are a number of different autoimmune disorders with similar features to Multiple Sclerosis (MS), such as neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody disorder (MOGAD). These diseases share striking similarities that ultimately affect the way in which our communities understand and manage the diagnosis. Hence, it is of utmost importance for […]

Partenaires Industriels

Ils nous soutiennent